跳至主要内容
临床试验/NCT05410015
NCT05410015招募中不适用

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Via Analysis of Immunoinflammation-related Protein Complexes in Blood

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年2月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Immune Inflammation-Related Protein Pomplexes

研究概览

简要总结

The relationship between immune inflammation-related protein complexes inblood and recurrence or metastasis of ovarian cancer will be studied

详细描述

100 cases in normal ovarian control group, 100 cases in benign ovarian disease group and 100 cases in malignant ovarian epithelial carcinoma group will be studied. Change regularity of ovarian cancer specific immune inflammation-related protein complexes in blood will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Normal ovary control
  • Ovarian benign disease
  • Ovarian malignant epithelial carcinoma

排除标准

  • Age above 70
  • Suffering from other malignant tumors
  • Non-compliant patient

结局指标

主要结局

Immune Inflammation-Related Protein Pomplexes

时间窗: 2 years

The change of immune inflammation-related protein complexes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验